Point72 (Difc) LTD Vanda Pharmaceuticals Inc. Transaction History
Point72 (Difc) LTD
- $3.17 Trillion
- Q1 2024
A detailed history of Point72 (Difc) LTD transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 16,301 shares of VNDA stock, worth $87,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,301Holding current value
$87,373% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNDA
# of Institutions
148Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$43.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$22.9 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$18.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$12.7 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$9.66 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $303M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...